SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Capital Product Partners L.P. (NASDAQ:CPLP) recently announced its Current Deferred Revenue, which stood at a sum of $10.867 Million. The company, in its website, informed the investors that the comprehensive income of company for the year ending 31 December 2015 was $-0.462 million.

Cost of goods sold

Capital Product Partners, during the same duration, sold goods worth $77.223 million in the market. This was the amount for the quarter that ended on 31 December 2015.

In the meanwhile, the company made a consolidated net income/loss for the same fiscal at $55.41 million.

Deferred revenue of the company

For this period, the company announced that its deferred revenue was $10.867 million. In the non-current status, the deferred revenue was $0.921 million for quarter ending on 31 December 2015.

Deferred revenue for Capital Product Partners is a parameter that defines corporation’s capitals attained before paying off supply stuffs or allied services to the customers. Deferred revenue is also termed as “obligation.” The company also said that during the business cycle, recording deferred revenue is something that is a common practice among all.

Common shares count

The company had a 120.409 number of shares for the previous year and quarter that ended on same date. The earnings before interest and taxes, or EBIT stood at $73.806 million, for the quarter that ended on 31 December 2015. Capital Product Partners L.P. reported a 73.806% EBIT margin for this quarter.

During this duration, the company said that it settled an amount of $7.7886 million for the year and quarter that ended on 31 December 2015. This was termed as “book value” in Capital Product Partners L.P.’s balance sheets.

The company is yet to release the official statement or balance sheet summary for this year. The former sheet will give a comparison ground to analysts for measuring where Capital Product Partners L.P. stands today. The company may release the figures for this year later.